These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38561593)

  • 1. Clinical Analysis and Mental Health Survey of Hemophilia Carriers: a Cross-sectional Study.
    Wang W; Jiang LJ; Cui DY; Zhang A; Wang X; Liu AG; Hu Q
    Curr Med Sci; 2024 Apr; 44(2):435-440. PubMed ID: 38561593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding in carriers of hemophilia.
    Plug I; Mauser-Bunschoten EP; Bröcker-Vriends AH; van Amstel HK; van der Bom JG; van Diemen-Homan JE; Willemse J; Rosendaal FR
    Blood; 2006 Jul; 108(1):52-6. PubMed ID: 16551972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of carrier status in female members of Japanese hemophilia families.
    Shinozawa K; Amano K; Hagiwara T; Bingo M; Chikasawa Y; Inaba H; Kinai E; Fukutake K
    J Thromb Haemost; 2021 Jun; 19(6):1493-1505. PubMed ID: 33760382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.
    Garagiola I; Mortarino M; Siboni SM; Boscarino M; Mancuso ME; Biganzoli M; Santagostino E; Peyvandi F
    Eur J Hum Genet; 2021 Feb; 29(2):241-249. PubMed ID: 33082527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.
    Rydz N; Leggo J; Tinlin S; James P; Lillicrap D
    Am J Hematol; 2013 Dec; 88(12):1030-4. PubMed ID: 23913812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing.
    Lyu C; Xue F; Liu X; Liu W; Fu R; Sun T; Wu R; Zhang L; Li H; Zhang D; Yang R; Zhang L
    Haemophilia; 2016 Sep; 22(5):e427-34. PubMed ID: 27292088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis and quality of life survey of hemophilia B patients in the central and western regions of China.
    Wang W; Xu L; Wu J; Liu W; Jin J; Huang J; Xu Z; Huang Y; Li B; Liu Y; Zhang Q; Zhou M; Peng J; Hu Q
    Front Pediatr; 2024; 12():1366990. PubMed ID: 38783919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience.
    González-Ramos IA; Mantilla-Capacho JM; Luna-Záizar H; Mundo-Ayala JN; Lara-Navarro IJ; Ornelas-Ricardo D; González Alcázar JÁ; Evangelista-Castro N; Jaloma-Cruz AR
    Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):939-954. PubMed ID: 33191626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
    Olsson A; Hellgren M; Berntorp E; Ljung R; Baghaei F
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):471-5. PubMed ID: 24509327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia carrier's awareness, diagnosis, and management in emerging countries: a cross-sectional study in Côte d'Ivoire (Ivory Coast).
    Lambert C; Meité ND; Sanogo I; Lobet S; Adjambri E; Eeckhoudt S; Hermans C
    Orphanet J Rare Dis; 2019 Feb; 14(1):26. PubMed ID: 30709356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia in Iran.
    Dorgalaleh A; Dadashizadeh G; Bamedi T
    Hematology; 2016 Jun; 21(5):300-10. PubMed ID: 26914731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Bleeding Tendency in Sudanese Female Carriers of Hemophilia B.
    Abker IAA; Elzaki SG; Elmahdi SA; Tayrab JE; Ahmed SM; Tayrab E
    Biomed Res Int; 2022; 2022():6756130. PubMed ID: 35782080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation.
    Radic CP; Rossetti LC; Abelleyro MM; Tetzlaff T; Candela M; Neme D; Sciuccati G; Bonduel M; Medina-Acosta E; Larripa IB; de Tezanos Pinto M; De Brasi CD
    J Thromb Haemost; 2015 Apr; 13(4):530-9. PubMed ID: 25611311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
    Trinchero A; Sholzberg M; Matino D
    Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application study on inversion diagnosis of F8 gene in hemophilia A].
    Qi LY; Jin CL; Lin CK; Ren MH; Dong WH; Sun KL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):405-8. PubMed ID: 17680530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.